Samalizumab, CAS 1073059-33-2

Product Description: Samalizumab (ALXN 6000) is a humanized monoclonal antibody that specifically binds to CD200 and blocks its ligation to the CD200 receptor (CD200R). Samalizumab can be used for multiple myeloma and B-cell chronic lymphocytic leukemia research[1].

Applications: Cancer-programmed cell death

Formula: N/A

References: [1]Daruka Mahadevan, et al. Phase I study of samalizumab in chronic lymphocytic leukemia and multiple myeloma: blockade of the immune checkpoint CD200. J Immunother Cancer. 2019 Aug 23;7(1):227.

CAS Number: 1073059-33-2

Molecular Weight: N/A

Compound Purity: 99.81

Research Area: Cancer

Solubility: 10 mM in DMSO

Target: Others

• Artikelnummer: MEXHY-P99400-10
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99400-10
• Green Labware: Nein
• Verpackungseinheit: 10 mg
• Mengeneinheit: STK